ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001791916

Bios Fund III QP, LP

CIK 0001791916 Name as filed on the most recent filing

Filed as Bios Fund III QP, LP (10)

36 transaction lines · from 10 filings · filed 2022-08-17 to 2025-06-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-06-27 Actuate Therapeutics, Inc.
ACTU 		P, Open-market purchase 71,428 acquired 7.00 499,996.00 Form 4, filing 0001104659-25-063991
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 17,361 disposed 8.00 138,888.00 Form 4, filing 0001104659-24-091371
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 5,314 disposed 8.00 42,512.00 Form 4, filing 0001104659-24-091371
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 2,324 disposed 8.00 18,592.00 Form 4, filing 0001104659-24-091371
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 17,361 disposed 9.00 156,249.00 Form 4, filing 0001104659-24-089822
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 5,314 disposed 9.00 47,826.00 Form 4, filing 0001104659-24-089822
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		S, Open-market sale 2,324 disposed 9.00 20,916.00 Form 4, filing 0001104659-24-089822
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		P, Open-market purchase 375,000 acquired 8.00 3,000,000.00 Form 4, filing 0001104659-24-089822
2024-08-14 Actuate Therapeutics, Inc.
ACTU 		P, Open-market purchase 125,000 acquired 8.00 1,000,000.00 Form 4, filing 0001104659-24-089822
2023-06-21 Azitra Inc
AZTR 		S, Open-market sale 509,141 disposed Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		S, Open-market sale 82,223 disposed Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		S, Open-market sale 77,953 disposed Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 1,291,258 acquired Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 456,412 acquired 5.00 2,282,060.00 Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 208,531 acquired Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 197,701 acquired Not reported Not priced Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 73,708 acquired 5.00 368,540.00 Form 4, filing 0001104659-23-074424
2023-06-21 Azitra Inc
AZTR 		P, Open-market purchase 69,880 acquired 5.00 349,400.00 Form 4, filing 0001104659-23-074424
2022-12-12 In8Bio, Inc.
INAB 		P, Open-market purchase 57,052 acquired 2.48 141,420.50 Form 4, filing 0001104659-22-126432
2022-12-12 In8Bio, Inc.
INAB 		P, Open-market purchase 9,214 acquired 2.48 22,839.66 Form 4, filing 0001104659-22-126432
2022-12-12 In8Bio, Inc.
INAB 		P, Open-market purchase 8,735 acquired 2.48 21,652.32 Form 4, filing 0001104659-22-126432
2022-11-28 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 12,220 acquired 2.65 32,379.33 Form 4, filing 0001104659-22-122622
2022-11-28 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 1,973 acquired 2.65 5,227.86 Form 4, filing 0001104659-22-122622
2022-11-28 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 1,871 acquired 2.65 4,957.59 Form 4, filing 0001104659-22-122622
2022-11-16 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 54,009 acquired 1.40 75,612.60 Form 4, filing 0001104659-22-119719
2022-11-16 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 8,722 acquired 1.40 12,210.80 Form 4, filing 0001104659-22-119719
2022-11-16 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 8,269 acquired 1.40 11,576.60 Form 4, filing 0001104659-22-119719
2022-11-15 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 1,141,030 acquired 1.20 1,369,236.00 Form 4, filing 0001104659-22-119339
2022-11-15 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 184,270 acquired 1.20 221,124.00 Form 4, filing 0001104659-22-119339
2022-11-15 Cognition Therapeutics Inc
CGTX 		P, Open-market purchase 174,700 acquired 1.20 209,640.00 Form 4, filing 0001104659-22-119339
2022-09-28 In8Bio, Inc.
INAB 		P, Open-market purchase 19,017 acquired 2.02 38,440.96 Form 4, filing 0001104659-22-103860
2022-09-28 In8Bio, Inc.
INAB 		P, Open-market purchase 3,070 acquired 2.02 6,205.70 Form 4, filing 0001104659-22-103860
2022-09-28 In8Bio, Inc.
INAB 		P, Open-market purchase 2,913 acquired 2.02 5,888.34 Form 4, filing 0001104659-22-103860
2022-08-16 In8Bio, Inc.
INAB 		P, Open-market purchase 1,349,218 acquired 1.90 2,563,514.20 Form 4, filing 0001104659-22-092057
2022-08-16 In8Bio, Inc.
INAB 		P, Open-market purchase 217,891 acquired 1.90 413,992.90 Form 4, filing 0001104659-22-092057
2022-08-16 In8Bio, Inc.
INAB 		P, Open-market purchase 206,575 acquired 1.90 392,492.50 Form 4, filing 0001104659-22-092057

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. BIOS Fund III QP, LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001791916

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.